NYSE:NUS

Nu Skin Enterprises Stock Forecast, Price & News

$57.82

-0.21 (-0.36 %)

(As of 01/22/2021 12:00 AM ET)

Add

Compare

Today's Range

$57.30

Now: $57.82▼

$58.80

50-Day Range

$50.98

MA: $54.30▼

$59.04

52-Week Range

$12.31

Now: $57.82▼

$59.71

Volume234,145 shs

Average Volume373,346 shs

Market Capitalization$2.95 billion

P/E Ratio19.47

Dividend Yield2.58%

Beta1.37

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

MarketRank^™

Overall MarketRank^™

2.10 out of 5 stars

Consumer Staples Sector

22nd out of 301 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 14 stocks

1.2 Analyst's Opinion

Consensus Rating
Nu Skin Enterprises has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 3 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $56.50, Nu Skin Enterprises has a forecasted downside of 2.3% from its current price of $57.82.
Amount of Analyst Coverage
Nu Skin Enterprises has only been the subject of 1 research reports in the past 90 days.

2.6 Community Rank

Outperform Votes
Nu Skin Enterprises has received 499 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Nu Skin Enterprises has received 479 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Nu Skin Enterprises has received 51.02% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote “Outperform” if you believe NUS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.

2.5 Dividend Strength

Dividend Yield
Nu Skin Enterprises pays a meaningful dividend of 2.58%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Nu Skin Enterprises does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Nu Skin Enterprises is 48.39%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 40.32% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nu Skin Enterprises insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,170,631.00 in company stock.
Percentage Held by Insiders
Only 3.40% of the stock of Nu Skin Enterprises is held by insiders.
Percentage Held by Institutions
73.75% of the stock of Nu Skin Enterprises is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5 Earnings and Valuation

Earnings Growth
Earnings for Nu Skin Enterprises are expected to grow by 9.41% in the coming year, from $3.40 to $3.72 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Nu Skin Enterprises is 19.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.95.
Price to Earnings Ratio vs. Sector
The P/E ratio of Nu Skin Enterprises is 19.47, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 42.09.
Price to Earnings Growth Ratio
Nu Skin Enterprises has a PEG Ratio of 2.03. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Nu Skin Enterprises has a P/B Ratio of 3.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Drugs, proprietaries, & sundries

Sub-IndustryPersonal Products

SectorConsumer Staples

Current SymbolNYSE:NUS

Previous Symbol

CUSIP67018T10

CIK1021561

Webwww.nuskinenterprises.com

Phone801-345-1000

Employees4,900

Debt

Debt-to-Equity Ratio0.38

Current Ratio1.66

Quick Ratio1.08

Price-To-Earnings

Trailing P/E Ratio19.47

Forward P/E Ratio17.01

P/E Growth2.03

Sales & Book Value

Annual Sales$2.42 billion

Price / Sales1.22

Cash Flow$4.73 per share

Price / Cash Flow12.22

Book Value$15.74 per share

Price / Book3.67

Profitability

EPS (Most Recent Fiscal Year)$3.10

Net Income$173.55 million

Net Margins6.54%

Return on Equity19.18%

Return on Assets8.87%

Miscellaneous

Outstanding Shares51,031,000

Market Cap$2.95 billion

Next Earnings Date2/11/2021 (Confirmed)

OptionableOptionable

$57.82

-0.21 (-0.36 %)

(As of 01/22/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.

Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

How has Nu Skin Enterprises' stock price been impacted by Coronavirus?

Nu Skin Enterprises' stock was trading at $21.06 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NUS stock has increased by 174.5% and is now trading at $57.82.
View which stocks have been most impacted by COVID-19.

Is Nu Skin Enterprises a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View analyst ratings for Nu Skin Enterprises or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Nu Skin Enterprises?

Wall Street analysts have given Nu Skin Enterprises a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nu Skin Enterprises wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises CEO Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among Nu Skin Enterprises' employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Nu Skin Enterprises.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) released its earnings results on Wednesday, November, 4th. The company reported $1.08 earnings per share for the quarter, topping analysts' consensus estimates of $0.99 by $0.09. The company earned $703.35 million during the quarter, compared to the consensus estimate of $703.35 million. Nu Skin Enterprises had a net margin of 6.54% and a trailing twelve-month return on equity of 19.18%. The company's revenue was up 19.2% compared to the same quarter last year. During the same period last year, the firm posted $0.79 earnings per share.
View Nu Skin Enterprises' earnings history.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises declared a quarterly dividend on Wednesday, November 4th. Investors of record on Friday, November 27th will be given a dividend of $0.375 per share on Wednesday, December 9th. This represents a $1.50 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date of this dividend is Wednesday, November 25th.
View Nu Skin Enterprises' dividend history.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises pays an annual dividend of $1.50 per share and currently has a dividend yield of 2.58%. The dividend payout ratio of Nu Skin Enterprises is 48.39%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 40.32% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.
View Nu Skin Enterprises' dividend history.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its fourth quarter earnings guidance on Wednesday, November, 4th. The company provided earnings per share (EPS) guidance of $1.10-1.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.02. The company issued revenue guidance of $720-750 million, compared to the consensus revenue estimate of $714.68 million.

What price target have analysts set for NUS?

7 equities research analysts have issued twelve-month price targets for Nu Skin Enterprises' shares. Their forecasts range from $41.00 to $68.00. On average, they anticipate Nu Skin Enterprises' share price to reach $56.50 in the next twelve months. This suggests that the stock has a possible downside of 2.3%.
View analysts' price targets for Nu Skin Enterprises or view Wall Street analyst' top-rated stocks.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a increase in short interest in December. As of December 31st, there was short interest totaling 1,190,000 shares, an increase of 58.8% from the December 15th total of 749,400 shares. Based on an average daily trading volume, of 368,300 shares, the short-interest ratio is presently 3.2 days. Currently, 2.4% of the company's stock are sold short.
View Nu Skin Enterprises' Short Interest.

Who are some of Nu Skin Enterprises' key competitors?

Some companies that are related to Nu Skin Enterprises include The Estée Lauder Companies (EL), Herbalife Nutrition (HLF), Medifast (MED), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), USANA Health Sciences (USNA), Veru (VERU), Revlon (REV) and Nature's Sunshine Products (NATR).
View all of NUS's competitors.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the following people:

Mr. Steven J. Lund, Exec. Chairman (Age 68, Pay $627.58k)
Mr. Ritch N. Wood, CEO & Director (Age 55, Pay $1.14M)
Mr. Ryan S. Napierski, Pres (Age 47, Pay $810.16k)
Mr. Mark H. Lawrence, Exec. VP & CFO (Age 51, Pay $589.84k)
Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 68, Pay $777.63k)
Mr. D. Matthew Dorny, Exec. VP, Gen. Counsel & Sec. (Age 57, Pay $581.23k)
Mr. Blake M. Roney, Founder (Age 62)
Ms. Sandra N. Tillotson, Founder (Age 64)
Mr. James D. Thomas, Chief Accounting Officer (Age 43)
Mr. Vince Perfetti, Chief Transformation Officer & Sr. VP of Technology

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by many different retail and institutional investors. Top institutional shareholders include Candriam Luxembourg S.C.A. (0.07%), State of Alaska Department of Revenue (0.04%) and Pacer Advisors Inc. (0.03%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Foulis Greg, Joseph Y Chang, Mark H Lawrence, Ritch N Wood and Ryan S Napierski.
View institutional ownership trends for Nu Skin Enterprises.

Which institutional investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc.. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Joseph Y Chang, Mark H Lawrence, and Ryan S Napierski.
View insider buying and selling activity for Nu Skin Enterprises or view top insider-selling stocks.

Which institutional investors are buying Nu Skin Enterprises stock?

NUS stock was bought by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., and State of Alaska Department of Revenue.
View insider buying and selling activity for Nu Skin Enterprises or or view top insider-buying stocks.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $57.82.

How big of a company is Nu Skin Enterprises?

Nu Skin Enterprises has a market capitalization of $2.95 billion and generates $2.42 billion in revenue each year. The company earns $173.55 million in net income (profit) each year or $3.10 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is www.nuskinenterprises.com.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]

This page was last updated on 1/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here